Dashboard MRSA
Repurposing candidates for MRSA
Methicillin-resistant Staphylococcus aureus
Approved medicines with AI-predicted activity ≥40% against MRSA, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 860
- Existing antimicrobials set aside
- 117
- Needing review
- 72
- Repurposing candidates
- 671
Repurposing candidates for MRSA
AI prediction · nothing measuredAll 671 repurposing candidates for MRSA.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Atracurium BesylateExisting use: Neuromuscular Blockade50.3% AI-predicted activityagainst MRSA50+ registered studies
- Cisatracurium BesylateExisting use: Other quaternary ammonium compounds50.3% AI-predicted activityagainst MRSA50+ registered studies
- NevirapineExisting use: HIV infection, HIV-1 infection, Viral disease50.2% AI-predicted activityagainst MRSA50+ registered studies
- BoceprevirExisting use: Chronic hepatitis C virus infection, Viral disease50.1% AI-predicted activityagainst MRSA50+ registered studies
- DoravirineExisting use: HIV infection, HIV-1 infection, Viral disease50.0% AI-predicted activityagainst MRSA50+ registered studies
- EszopicloneExisting use: Insomnia50.0% AI-predicted activityagainst MRSA50+ registered studies
- Lapatinib DitosylateExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 1 more50.0% AI-predicted activityagainst MRSA50+ registered studies
- Mitapivat SulfateExisting use: Anemia, Familial hemolytic anemia, Genetic disorder50.0% AI-predicted activityagainst MRSA19 registered studies
- Oxymetazoline HydrochlorideExisting use: Allergic rhinitis, Common cold, Eye allergy and 5 more50.0% AI-predicted activityagainst MRSA50+ registered studies
- PrednisoloneExisting use: Allergic conjunctivitis, Allergic rhinitis, Ankylosing spondylitis and 55 more50.0% AI-predicted activityagainst MRSA39 registered studies
- DeserpidineExisting use: Hypertension50.0% AI-predicted activityagainst MRSANo documented evidence found
- DesogestrelExisting use: Progestogens50.0% AI-predicted activityagainst MRSA50+ registered studies
- Momelotinib DihydrochlorideExisting use: Essential thrombocythemia, Polycythemia vera, Primary myelofibrosis50.0% AI-predicted activityagainst MRSANo documented evidence found
- CalcifediolExisting use: Chronic kidney disease, Parathyroid disease, Secondary hyperparathyroidism49.9% AI-predicted activityagainst MRSA50+ registered studies
- CabergolineExisting use: Hypothalamic neoplasm, Parkinson disease49.9% AI-predicted activityagainst MRSA50+ registered studies
- EnzalutamideExisting use: Cancer, Metastatic prostate cancer, Neoplasm and 4 more49.8% AI-predicted activityagainst MRSA50+ registered studies
- Nalmefene HydrochlorideExisting use: Alcohol dependence49.8% AI-predicted activityagainst MRSA39 registered studies
- Hydroxychloroquine SulfateExisting use: Malaria, Rheumatoid arthritis49.7% AI-predicted activityagainst MRSA50+ registered studies
- AlvimopanExisting use: Constipation49.6% AI-predicted activityagainst MRSA26 registered studies
- IvabradineExisting use: Angina pectoris, Cardiovascular disease, Congestive heart failure and 1 more49.6% AI-predicted activityagainst MRSA50+ registered studies
- TriamcinoloneExisting use: Airway obstruction, Eye inflammation, Hemorrhoid and 2 more49.6% AI-predicted activityagainst MRSA50+ registered studies
- BexagliflozinExisting use: Diabetes mellitus, Type 2 diabetes mellitus49.6% AI-predicted activityagainst MRSA21 registered studies
- CalcitriolExisting use: Chronic kidney disease, Hypocalcemia, Hypoparathyroidism and 2 more49.5% AI-predicted activityagainst MRSA50+ registered studies
- CapecitabineExisting use: Actinic keratosis, Adenocarcinoma, Basal cell carcinoma and 19 more49.5% AI-predicted activityagainst MRSA50+ registered studies